{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:28:48Z","timestamp":1786998528890,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,4]],"date-time":"2027-03-04T00:00:00Z","timestamp":1804118400000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS118177"],"award-info":[{"award-number":["R01 NS118177"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS115977"],"award-info":[{"award-number":["R01 NS115977"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017026","name":"Spastic Paraplegia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018535","name":"The Cotswold Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018535","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ymthe.2025.11.029","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:18:11Z","timestamp":1764202691000},"page":"1729-1742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intracerebroventricular SPAST-AAV9 gene therapy prevents manifestation of symptoms in a mouse model of SPG4 hereditary spastic paraplegia"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6393-0473","authenticated-orcid":false,"given":"Emanuela","family":"Piermarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrobona","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Gray-Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Sena-Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Baas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.11.029_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.conb.2018.04.025","article-title":"Converging cellular themes for the hereditary spastic paraplegias","volume":"51","author":"Blackstone","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.ymthe.2025.11.029_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrn2946","article-title":"Hereditary spastic paraplegias: membrane traffic and the motor pathway","volume":"12","author":"Blackstone","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ymthe.2025.11.029_bib3","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2023.12966","article-title":"A novel missense mutation in SPAST causes hereditary spastic paraplegia in male members of a family: A case report","volume":"27","author":"Wang","year":"2023","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ymthe.2025.11.029_bib4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/jnnp.69.2.150","article-title":"Hereditary spastic paraparesis: a review of new developments","volume":"69","author":"McDermott","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymthe.2025.11.029_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/15472","article-title":"Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia","volume":"23","author":"Hazan","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2025.11.029_bib6","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/hmg\/ddx125","article-title":"Mutant spastin proteins promote deficits in axonal transport through an isoform-specific mechanism involving casein kinase 2 activation","volume":"26","author":"Leo","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.11.029_bib7","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1523\/JNEUROSCI.3309-13.2014","article-title":"Pathogenic mutation of spastin has gain-of-function effects on microtubule dynamics","volume":"34","author":"Solowska","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.11.029_bib8","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1091\/mbc.e17-01-0047","article-title":"Truncating mutations of SPAST associated with hereditary spastic paraplegia indicate greater accumulation and toxicity of the M1 isoform of spastin","volume":"28","author":"Solowska","year":"2017","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ymthe.2025.11.029_bib9","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/hmg\/ddy419","article-title":"Hereditary spastic paraplegia: gain-of-function mechanisms revealed by new transgenic mouse","volume":"28","author":"Qiang","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.11.029_bib10","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/hmg\/ddab367","article-title":"Modeling gain-of-function and loss-of-function components of SPAST-based hereditary spastic paraplegia using transgenic mice","volume":"31","author":"Piermarini","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.11.029_bib11","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/stem.1569","article-title":"Loss of spastin function results in disease-specific axonal defects in human pluripotent stem cell-based models of hereditary spastic paraplegia","volume":"32","author":"Denton","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymthe.2025.11.029_bib12","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000715","article-title":"Microtubule-dependent and independent roles of spastin in lipid droplet dispersion and biogenesis","volume":"3","author":"Tadepalle","year":"2020","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.ymthe.2025.11.029_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.34","article-title":"Clinical development of gene therapy: results and lessons from recent successes","volume":"3","author":"Kumar","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.11.029_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.645","article-title":"Current developments of gene therapy in human diseases","volume":"5","author":"Liu","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.ymthe.2025.11.029_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to centre stage","volume":"526","author":"Naldini","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.11.029_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3233\/JHD-160215","article-title":"Cellular Analysis of Silencing the Huntington's Disease Gene Using AAV9 Mediated Delivery of Artificial Micro RNA into the Striatum of Q140\/Q140 Mice","volume":"5","author":"Keeler","year":"2016","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.ymthe.2025.11.029_bib17","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.11.029_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2016.09.011","article-title":"Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9","volume":"241","author":"Saraiva","year":"2016","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.11.029_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/srep22131","article-title":"AAV Gene Therapy for MPS1-associated Corneal Blindness","volume":"6","author":"Vance","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.11.029_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.618360","article-title":"Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I","volume":"14","author":"Belur","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymthe.2025.11.029_bib21","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.cell.2009.04.021","article-title":"Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model","volume":"137","author":"Kota","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.11.029_bib22","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nm.2791","article-title":"Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2","volume":"18","author":"Miyazaki","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.11.029_bib23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ana.24618","article-title":"Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model","volume":"79","author":"Stoica","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2025.11.029_bib24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nm1076","article-title":"RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia","volume":"10","author":"Xia","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.11.029_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003454","article-title":"Long-term follow-up after gene therapy for canavan disease","volume":"4","author":"Leone","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.11.029_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/gt.2008.149","article-title":"Mechanisms of distribution of mouse beta-galactosidase in the adult GM1-gangliosidosis brain","volume":"16","author":"Broekman","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.11.029_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ymthe.2005.04.019","article-title":"AAV2\/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2","volume":"12","author":"Lin","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.029_bib28","doi-asserted-by":"crossref","first-page":"13077","DOI":"10.1523\/JNEUROSCI.2518-14.2014","article-title":"An anti-neuroinflammatory that targets dysregulated glia enhances the efficacy of CNS-directed gene therapy in murine infantile neuronal ceroid lipofuscinosis","volume":"34","author":"Macauley","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.11.029_bib29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ymthe.2004.12.020","article-title":"AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy","volume":"11","author":"Rafi","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.029_bib30","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/mt.2010.299","article-title":"Efficacy of a combined intracerebral and systemic gene delivery approach for the treatment of a severe lysosomal storage disorder","volume":"19","author":"Spampanato","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.029_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nbd.2011.02.015","article-title":"Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I","volume":"43","author":"Wolf","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2025.11.029_bib32","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1089\/hum.2019.012","article-title":"Safe and Sustained Expression of Human Iduronidase After Intrathecal Administration of Adeno-Associated Virus Serotype 9 in Infant Rhesus Monkeys","volume":"30","author":"Hordeaux","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.11.029_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.omtm.2018.06.003","article-title":"Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Human Alpha-L-Iduronidase in Rhesus Macaques","volume":"10","author":"Hordeaux","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.11.029_bib34","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.gt.3302735","article-title":"Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice","volume":"13","author":"Watson","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.11.029_bib35","article-title":"Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10","volume":"24","author":"Belur","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymthe.2025.11.029_bib36","doi-asserted-by":"crossref","first-page":"14894","DOI":"10.1073\/pnas.1413645111","article-title":"Liver-directed gene therapy corrects cardiovascular lesions in feline mucopolysaccharidosis type I","volume":"111","author":"Hinderer","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.11.029_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1741-7007-6-31","article-title":"A cryptic promoter in the first exon of the SPG4 gene directs the synthesis of the 60-kDa spastin isoform","volume":"6","author":"Mancuso","year":"2008","journal-title":"BMC Biol."},{"key":"10.1016\/j.ymthe.2025.11.029_bib38","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/mds.30072","article-title":"Unraveling Isoform Complexity: The Roles of M1- and M87-Spastin in Spastic Paraplegia 4 (SPG4)","volume":"40","author":"Ramakrishnan","year":"2025","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymthe.2025.11.029_bib39","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1073\/pnas.1818824116","article-title":"Spastin is a dual-function enzyme that severs microtubules and promotes their regrowth to increase the number and mass of microtubules","volume":"116","author":"Kuo","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.11.029_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118862","article-title":"A newly identified NES sequence present in spastin regulates its subcellular localization and microtubule severing activity","volume":"1868","author":"Sakoe","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ymthe.2025.11.029_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11081081","article-title":"Therapeutic Strategies for Mutant SPAST-Based Hereditary Spastic Paraplegia","volume":"11","author":"Mohan","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.ymthe.2025.11.029_bib42","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.033704","article-title":"Functional differences of short and long isoforms of spastin harboring missense mutation","volume":"11","author":"Plaud","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymthe.2025.11.029_bib43","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1093\/hmg\/ddq177","article-title":"Evaluation of loss of function as an explanation for SPG4-based hereditary spastic paraplegia","volume":"19","author":"Solowska","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.11.029_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008665","article-title":"Spastin mutations impair coordination between lipid droplet dispersion and reticulum","volume":"16","author":"Arribat","year":"2020","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ymthe.2025.11.029_bib45","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.5051","article-title":"Molecular and cellular mechanisms of spastin in neural development and disease (Review)","volume":"48","author":"Liu","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.11.029_bib46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbamcr.2011.08.010","article-title":"The AAA ATPase spastin links microtubule severing to membrane modelling","volume":"1823","author":"Lumb","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2025.11.029_bib47","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1093\/brain\/awac122","article-title":"Store-operated calcium entry is reduced in spastin-linked hereditary spastic paraplegia","volume":"145","author":"Rizo","year":"2022","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2025.11.029_bib48","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2990.2004.00587.x","article-title":"The extent of axonal loss in the long tracts in hereditary spastic paraplegia","volume":"30","author":"Deluca","year":"2004","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ymthe.2025.11.029_bib49","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1523\/JNEUROSCI.3159-07.2008","article-title":"Quantitative and functional analyses of spastin in the nervous system: implications for hereditary spastic paraplegia","volume":"28","author":"Solowska","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2025.11.029_bib50","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/mds.28885","article-title":"A Novel SPAST Mutation Results in Spastin Accumulation and Defects in Microtubule Dynamics","volume":"37","author":"Chen","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ymthe.2025.11.029_bib51","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.4103\/1673-5374.313052","article-title":"Spastin interacts with collapsin response mediator protein 3 to regulate neurite growth and branching","volume":"16","author":"Ji","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ymthe.2025.11.029_bib52","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1471-4159.2005.03472.x","article-title":"Human spastin has multiple microtubule-related functions","volume":"95","author":"Salinas","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymthe.2025.11.029_bib53","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors","volume":"22","author":"Gray","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.11.029_bib54","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.omtm.2017.04.007","article-title":"Development of a Novel AAV Gene Therapy Cassette with Improved Safety Features and Efficacy in a Mouse Model of Rett Syndrome","volume":"5","author":"Gadalla","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.11.029_bib55","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1016\/j.ymthe.2023.07.013","article-title":"Novel MECP2 gene therapy is effective in a multicenter study using two mouse models of Rett syndrome and is safe in non-human primates","volume":"31","author":"Powers","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.11.029_bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2016.10.022","article-title":"Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug Administration","volume":"67","author":"Cohen-Pfeffer","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymthe.2025.11.029_bib57","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1592\/phco.29.7.832","article-title":"Intracerebroventricular administration of drugs","volume":"29","author":"Cook","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ymthe.2025.11.029_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000820","article-title":"Spastin depletion increases tubulin polyglutamylation and impairs kinesin-mediated neuronal transport, leading to working and associative memory deficits","volume":"18","author":"Lopes","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ymthe.2025.11.029_bib59","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/sj.ki.5001988","article-title":"Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay","volume":"71","author":"Keppler","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2025.11.029_bib60","doi-asserted-by":"crossref","first-page":"F339","DOI":"10.1152\/ajprenal.2000.278.3.F339","article-title":"Renal physiology of the mouse","volume":"278","author":"Meneton","year":"2000","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ymthe.2025.11.029_bib61","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65304","article-title":"The corticospinal tract primarily modulates sensory inputs in the mouse lumbar cord","volume":"10","author":"Moreno-Lopez","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2025.11.029_bib62","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/cne.20090","article-title":"The dorsolateral corticospinal tract in mice: an alternative route for corticospinal input to caudal segments following dorsal column lesions","volume":"472","author":"Steward","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ymthe.2025.11.029_bib63","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/382107","article-title":"Neurofilament Phosphorylation during Development and Disease: Which Came First, the Phosphorylation or the Accumulation?","volume":"2012","author":"Dale","year":"2012","journal-title":"J. Amino Acids"},{"key":"10.1016\/j.ymthe.2025.11.029_bib64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00310378","article-title":"Neurofilament phosphorylation is enhanced in cultured chick spinal cord neurons exposed to cerebrospinal fluid from amyotrophic lateral sclerosis patients","volume":"88","author":"Nagaraja","year":"1994","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2025.11.029_bib65","doi-asserted-by":"crossref","first-page":"866","DOI":"10.6026\/97320630019866","article-title":"A short review on behavioural assessment methods in rodents","volume":"19","author":"K","year":"2023","journal-title":"Bioinformation"},{"key":"10.1016\/j.ymthe.2025.11.029_bib66","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.hest.2020.09.001","article-title":"Behavioral tests in rodent models of stroke","volume":"1","author":"Ruan","year":"2020","journal-title":"Brain Hemorrhages"},{"key":"10.1016\/j.ymthe.2025.11.029_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00625-8","article-title":"Gait performance of adolescent mice assessed by the CatWalk XT depends on age, strain and sex and correlates with speed and body weight","volume":"11","author":"Pitzer","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.11.029_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164623","article-title":"Gait Patterns in Patients with Hereditary Spastic Paraparesis","volume":"11","author":"Serrao","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.11.029_bib69","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/hmg\/ddv632","article-title":"Conserved pharmacological rescue of hereditary spastic paraplegia-related phenotypes across model organisms","volume":"25","author":"Julien","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.11.029_bib70","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1172\/JCI24694","article-title":"Disease-related phenotypes in a Drosophila model of hereditary spastic paraplegia are ameliorated by treatment with vinblastine","volume":"115","author":"Orso","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.11.029_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0020429","article-title":"Drosophila spastin regulates synaptic microtubule networks and is required for normal motor function","volume":"2","author":"Sherwood","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ymthe.2025.11.029_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104619","article-title":"Optimizing intracellular antibodies (intrabodies\/nanobodies) to treat neurodegenerative disorders","volume":"134","author":"Messer","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2025.11.029_bib73","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41434-021-00224-2","article-title":"Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice","volume":"28","author":"Hana","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.11.029_bib74","article-title":"Intracerebroventricular viral injection of the neonatal mouse brain for persistent and widespread neuronal transduction","volume":"51863","author":"Kim","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ymthe.2025.11.029_bib75","article-title":"Neural labeling and manipulation by neonatal intraventricular viral injection in mice","volume":"3","author":"Wang","year":"2022","journal-title":"STAR Protoc."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625009682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625009682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T20:36:47Z","timestamp":1776371807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625009682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1525001625009682"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.11.029","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracerebroventricular SPAST-AAV9 gene therapy prevents manifestation of symptoms in a mouse model of SPG4 hereditary spastic paraplegia","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}